Syngene, a world-leading manufacturer of image analysis solutions, is delighted to introduce its new look gel doc and blot imaging system on Stand Z4, C50 at MEDLAB on 4 – 7 February. This compact system is an excellent choice for cost-conscious scientists who need a versatile and simple-to-use gel doc imaging system.
For scientists wanting a complete workstation, the NuGenius is the ideal gel doc. This powerful system features an internal processor and 5 million-pixel camera with motor driven zoom lens, guaranteeing incredible at-system image capture with gels of up to 20cm x 24cm.
The NuGenius gel doc system features a compact light-tight darkroom where researchers can choose to fit a UV transilluminator for ethidium bromide gels, a blue light transilluminator for SYBR® Safe and GelGreen™ DNA gels and a White Light Converter screen option to visualise protein gels stained with Coomassie Blue, providing maximum gel imaging versatility at minimal cost.
NuGenius also comes with an option for stain free applications – the NuGenius+. NuGenius+ can be automatically set up in seconds to capture great images of TGX Stain-Free™ FastCast™ acrylamide gels, Mini-PROTEAN® and Criterion™ TGX Stain-Free™ precast gels. Utilising this cost-effective system for imaging stain-free gels will save researchers hours of staining preparation time.
Both systems come with unlimited copies of GeneTools software, allowing scientists to rapidly analyse samples and store or print high resolution and publication quality images on any computer, as and when they need to.
For more details on the new-look Syngene imagers, scientists should click these links:
“We’re excited to be introducing our new-look imaging systems on Stand Z4, C50 at MedLab this year because they combine the latest in technology and value that modern scientists demand”, states Kate George, Sales & Technical Director. “We look forward to showing them the new range and to discussing how Syngene imagers can improve their research results by capturing the best gel and blot images.”